Mirati Therapeutics (MRTX) PT Lowered to $37 at Morgan Stanley

August 9, 2023 8:18 AM EDT Send to a Friend
Morgan Stanley analyst Michael Ulz ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login